Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Scott Liu
Scott Liu

President and CEO of Shanghai Henlius Biotech Inc.

Dr. Scott Liu, President and CEO of Shanghai Henlius Biotech Inc., has a Ph.D. degree in biology from Purdue University.  He also had a postdoctoral training in biology at Stanford University, and later studied business administration (iMBA courses) at Syracuse University.  Dr. Liu has many years of experience in management and leadership.  He has previously served as a VP of R&D of United Biomedical, the fouding director of the Biologics QC department of Bristol-Myers Squibb-Syracuse, and the QAL (QC) director of Amgen-Fremont.  Dr. Liu was a key member of the CMC teams for the late-phase development and commercial cGMP manufacturing of Orencia and Vectibix.  Because of his outstanding achievement, Dr. Liu has won the Bristol-Myers Squibb Company's Tech Ops President Award.  Liu Scott has 21 years of experience in biopharmaceutical R&D, regulatory affairs and quality operations, and he was awarded the title of "1000 Expert of Shanghai" in 2013.  At the same time, Dr. Liu assisted the formation of“Quality Alliance of Protein Therapeutics”and helped the CDE of CFDA in the establishment and improvement of the quality standards for protein therapeutics in China.  He also took the lead to promote an industry-wide adoption of single-use technologies into clinical and commercialization of manufacturing of monoclonal antibody drugs; and actively participated in the development of 《Technical Guidelines of Biosimilar Development and Evaluation》to promote the innovation and globalization of the biopharmaceutical industry of China.  Under his leadership, Henlius has successfully developed and moved into clinical trials six mAb therapeutics (including one innovative mAb), and the first two of which are in phase 3 trials.  Henlius has also successfully built a commercial biologics manufacturing facility in Shanghai in 2016, and obtained an EU QP’s declaration of GMP for conducting the clinical trials of its first four biosimilar products in Europe.